GLOBEIMMUNE INC
DelistedCIK 1245104fmd_01JWZNRWWN6TDNCDZ9G9538214Manufacturing · Pharmaceutical PreparationsTemplate: Standard
Coverage: Jan 01, 2012 to Mar 31, 2016, 13 periods
Latest annual · FY2015
Millions- Total revenues
- 6
- Operating income
- (3)
- Net income
- (3)
- Free cash flow
- (7)
Latest quarter · Q1 FY2016
Millions- Total revenues
- 1
- Operating income
- (1)
- Net income
- (1)
- Free cash flow
- (1)
Key stats
Open AnalysisCompound annual growth
- Revenue, 3 yearsFY2012 to FY2015
- -23.9%
GLOBEIMMUNE INC financials: quick answers
Annual figures as filed with the SEC. Each number links to the filing it came from and to its proof.
| Metric | FY2015 | FY2014 | Change | Source |
|---|---|---|---|---|
| Revenue | $6.5 million | $6 million | +8.2% | 10-K 2016-03-16 · proof |
| Operating income | -$2.8 million | -$5.8 million | 10-K 2016-03-16 · proof | |
| Net income | -$2.8 million | -$16.3 million | 10-K 2016-03-16 · proof | |
| Cash from operating activities | -$7.1 million | -$10.1 million | 10-K 2016-03-16 · proof | |
| Free cash flow | -$7.2 million | -$10.3 million | 10-K 2016-03-16 · proof | |
| Total assets | $11.5 million | $18.4 million | -37.4% | 10-K 2016-03-16 · proof |
| Total liabilities | $8.5 million | $12.8 million | -33.3% | 10-K 2016-03-16 · proof |
| Cash and cash equivalents | $9.9 million | $16.8 million | -41.1% | 10-K 2016-03-16 · proof |
- What was GLOBEIMMUNE INC's revenue in fiscal 2015?
- GLOBEIMMUNE INC reported revenue of $6.5 million for fiscal 2015 (the year ended Dec 31, 2015), against $6 million the year before (+8.2%). Source: the 10-K filed with the SEC on Mar 16, 2016. SEC
- What was GLOBEIMMUNE INC's operating income in fiscal 2015?
- GLOBEIMMUNE INC reported operating income of -$2.8 million for fiscal 2015 (the year ended Dec 31, 2015), against -$5.8 million the year before. Source: the 10-K filed with the SEC on Mar 16, 2016. SEC
- What was GLOBEIMMUNE INC's net income in fiscal 2015?
- GLOBEIMMUNE INC reported net income of -$2.8 million for fiscal 2015 (the year ended Dec 31, 2015), against -$16.3 million the year before. Source: the 10-K filed with the SEC on Mar 16, 2016. SEC
- What was GLOBEIMMUNE INC's cash from operating activities in fiscal 2015?
- GLOBEIMMUNE INC reported cash from operating activities of -$7.1 million for fiscal 2015 (the year ended Dec 31, 2015), against -$10.1 million the year before. Source: the 10-K filed with the SEC on Mar 16, 2016. SEC
- What was GLOBEIMMUNE INC's free cash flow in fiscal 2015?
- GLOBEIMMUNE INC reported free cash flow of -$7.2 million for fiscal 2015 (the year ended Dec 31, 2015), against -$10.3 million the year before. Source: the 10-K filed with the SEC on Mar 16, 2016. SEC
- What are GLOBEIMMUNE INC's total assets?
- As of Dec 31, 2015, GLOBEIMMUNE INC reported total assets of $11.5 million, against $18.4 million a year earlier (-37.4%). Source: the 10-K filed with the SEC on Mar 16, 2016. SEC
- What are GLOBEIMMUNE INC's total liabilities?
- As of Dec 31, 2015, GLOBEIMMUNE INC reported total liabilities of $8.5 million, against $12.8 million a year earlier (-33.3%). Source: the 10-K filed with the SEC on Mar 16, 2016. SEC
- What are GLOBEIMMUNE INC's cash and cash equivalents?
- As of Dec 31, 2015, GLOBEIMMUNE INC reported cash and cash equivalents of $9.9 million, against $16.8 million a year earlier (-41.1%). Source: the 10-K filed with the SEC on Mar 16, 2016. SEC
Read from the FinancialMD API on Nov 14, 2026. Values change only when a new filing is made; see the Financials tab for every period and as-of replay.
The same numbers for an agent, with proof on every value:
curl "https://api.financial.md/v1/company/financials/income_statement/standardized?company=cik:1245104&period_type=annual&limit=5"Information only, not investment advice.